Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Gynecologic 1

Conditions

Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Precancerous Conditions 1

Interventions

Biopsy 8Polymerase Chain Reaction 6Peripheral Blood Stem Cell Transplantation 5Epoetin Alfa 5Sulindac 4Microarray Analysis 4Gene Expression Profiling 4Cyclophosphamide 4Colposcopy 4Cetuximab 4Celecoxib 4fludarabine phosphate 3Vaginal Smears 3Selenium 3Methotrexate 3Imiquimod 3Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 3Eflornithine 3Darbepoetin alfa 3Aspirin 3Antilymphocyte Serum 3Whole-Body Irradiation 2Vitamin E 2Tacrolimus 2Radiotherapy, Intensity-Modulated 2Methylprednisolone 2Light Coagulation 2Interferon-alpha 2In Situ Hybridization, Fluorescence 2Immunohistochemistry 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Precancerous Conditions × human papillomavirus vaccine, TA × Clear all
NCT00788164 2023-08-31

Vaccine Therapy With or Without Imiquimod in Treating Patients With Grade 3 Cervical Intraepithelial Neoplasia

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1 Completed
75 enrolled
GynecologicOther neoplasm

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡